106 related articles for article (PubMed ID: 19450091)
1. Symbicort: a pharmacoeconomic review.
Halpin DM
J Med Econ; 2008; 11(2):345-62. PubMed ID: 19450091
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
Price D; Wirén A; Kuna P
Allergy; 2007 Oct; 62(10):1189-98. PubMed ID: 17845590
[TBL] [Abstract][Full Text] [Related]
3. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF
Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845
[TBL] [Abstract][Full Text] [Related]
5. Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma.
Brüggenjürgen B; Selim D; Kardos P; Richter K; Vogelmeier C; Roll S; Meyer-Sabellek W; Buhl R; Willich SN
Pharmacoeconomics; 2005; 23(7):723-31. PubMed ID: 15987228
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M
J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
[TBL] [Abstract][Full Text] [Related]
7. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study.
FitzGerald JM; Sears MR; Boulet LP; Becker AB; McIvor AR; Ernst P; Smiljanic-Georgijev NM; Lee JS;
Can Respir J; 2003; 10(8):427-34. PubMed ID: 14679407
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study.
Ige OM; Ohaju-Obodo JO; Chukwu C; Peters EJ; Okpapi J; Chukwuka C
Afr J Med Med Sci; 2010 Sep; 39(3):165-72. PubMed ID: 21416785
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].
Zyryanov SK; Dyakov IN; Aisanov ZR
Ter Arkh; 2022 Aug; 94(7):850-858. PubMed ID: 36286942
[TBL] [Abstract][Full Text] [Related]
10. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
Price D; Haughney J; Lloyd A; Hutchinson J; Plumb J
Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
Wickstrøm J; Dam N; Malmberg I; Hansen BB; Lange P
Clin Respir J; 2009 Jul; 3(3):169-80. PubMed ID: 20298400
[TBL] [Abstract][Full Text] [Related]
12. Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing.
Canonica GW; Castellani P; Cazzola M; Fabbri LM; Fogliani V; Mangrella M; Moretti A; Paggiaro P; Sanguinetti CM; Vignola AM;
Pulm Pharmacol Ther; 2004; 17(4):239-47. PubMed ID: 15219269
[TBL] [Abstract][Full Text] [Related]
13. Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma.
Miller E; Sears MR; McIvor A; Liovas A
Can Respir J; 2007; 14(5):269-75. PubMed ID: 17703241
[TBL] [Abstract][Full Text] [Related]
14. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
Lundborg M; Wille S; Bjermer L; Tilling B; Lundgren M; Telg G; Ekström T; Selroos O
Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy in asthma--fixed or variable dosing in different patients?
Lötvall J
Curr Med Res Opin; 2004 Nov; 20(11):1711-27. PubMed ID: 15537472
[TBL] [Abstract][Full Text] [Related]
16. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
17. Symbicort: controlling asthma in adults.
Lalloo U
Respir Med; 2002 Feb; 96 Suppl A():S16-22. PubMed ID: 11858561
[TBL] [Abstract][Full Text] [Related]
18. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
[TBL] [Abstract][Full Text] [Related]
19. Budesonide/formoterol: a review of its use in asthma.
Goldsmith DR; Keating GM
Drugs; 2004; 64(14):1597-618. PubMed ID: 15233594
[TBL] [Abstract][Full Text] [Related]
20. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
Buhl R; Vogelmeier C
Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]